CGT Catapult enters into regenerative medicines partnership with Global Stem Cells and Regenerative Medicine Acceleration Center

Memorandum of Understanding between CGT Catapult and GSRAC provides prelude to cooperative relationship between UK and South Korea cell and gene therapy areas.

The Cell and Gene Therapy Catapult (CGT Catapult) has signed a Memorandum of Understanding (MoU) with the Global Stem Cells and Regenerative Medicine Acceleration Center (GSRAC), South Korea. This agreement demonstrates the shared ambition between the CGT Catapult and GSRAC, a strategic think-tank commissioned by the South Korean government to accelerate commercial development in regenerative medicine, and aims to explore the possibility of a cooperative relationship to raise the international reach of the respective organisations.

By co-operating with GSRAC, the CGT Catapult aims to connect major industry players in South Korea and the UK and support their endeavours by working strategically to increase the throughput of commercially driven research activity, alongside the sharing of know how, technologies and capabilities across geographies. Through the combined efforts outlined within the memorandum, GSRAC and the CGT Catapult hope to continue to increase the profile and standing of their countries in the cell and gene therapy space, advancing both organisations places at the forefront of cell and gene therapy research globally.

This Memorandum of Understanding is another fantastic opportunity for the Cell and Gene Therapy Catapult. It marks our first agreement with a South Korean organisation, and through this agreement we will extend the Catapult’s profile and highlight the UK’s position as a global leader in this exciting sector. We hope that by signing this agreement we can foster stronger links between industries in both nations.

Keith Thompson, CEO, Cell and Gene Therapy Catapult

The GSRAC plays a vital role in the development of commercial and business endeavours in the regenerative medicine sector in South Korea. Commissioned by the Ministry of Health and Welfare, the center conducts R&D strategic planning and commercialisation services at a global level. Through policy, commercialisation and network support, the GSRAC promote the practical use of technological innovation.

This Memorandum of Understanding with CGT Catapult is our first official engagement not only with the UK but in all of Europe. We believe that this Memorandum of Understanding will open a collaborative partnership between the two organisations in the cell therapy field and facilitate further cooperation in diverse ways at industry and government levels.

So Ra Park, Director, GSRAC